Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000059478-25-000256
Filing Date
2025-11-14
Accepted
2025-11-14 16:11:50
Documents
5
Period of Report
2025-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1763154706.html 3  
1 FORM 3 wk-form3_1763154706.xml 3 6432
2 EX-24 adriennebrownpoa.htm EX-24 1190
3 EX-24 adriennebrownpoa001.jpg GRAPHIC 203784
4 EX-24 adriennebrownpoa002.jpg GRAPHIC 184411
5 EX-24 adriennebrownpoa003.jpg GRAPHIC 72089
  Complete submission text file 0000059478-25-000256.txt   643396
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Issuer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELI LILLY AND COMPANY 893 S DELAWARE STREET INDIANAPOLIS IN 46225
Business Address
Brown Adrienne S (Reporting) CIK: 0002096888 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06351 | Film No.: 251486243